OMEROS CORP Incentive from Lessor
OMEROS CORP (OMER) had Incentive from Lessor of $4.80 million as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Notes › Leases
us-gaap:IncentiveFromLessor · last filed 2015-03-16
- 2014-12-31: Incentive from Lessor $4.80M.
- 2013-12-31: Incentive from Lessor $4.50M.
- 2013-09-30: Incentive from Lessor $4.50M.
- 2013-06-30: Incentive from Lessor $4.40M.
| Period end | Incentive from Lessor |
|---|---|
| 2014-12-31 | $4.80M 10-K · filed 2015-03-16 |
| 2013-12-31 | $4.50M 10-K · filed 2014-03-13 |
| 2013-09-30 | $4.50M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $4.40M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $4.30M 10-Q · filed 2013-05-09 |
| 2012-11-30 | $206.00K 10-K · filed 2013-03-18 |
| 2012-03-30 | $3.00M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |